VILMORIN & CIE
*On a like-for-like basis.
Financial statements for fiscal year 2021-2022:Vilmorin & Cie once again demonstrates the resilience of its model by achieving solid commercial and financial performances
The consolidated financial statements for 2021-2022, closing on June 30, 2022, were approved by the Vilmorin&Cie Board at its meeting of October 12, 2022. The Statutory Auditors have examined this annual financial information with no particular comments or reservations to make in their conclusions.
In millions of euros
2021-2022
2020-2021
Variationwith current datavs. 2020-2021
Sales for the year
1,587.2
1,476.6
+7.5%
EBITDA
392.1
367.2
+24.9 M
Operating income
136.3
127.4
+8.9 M
Income from associated companies
17.9
26.3
-8.4 M
Financial result
-33.4
-46.9
+13.5 M
Income taxesOf which:
Current taxes
Deferred taxes
-25.4
-22.9-2.5
-13.4
-21.58.1
-12.0 M
-1.4 M-10.6 M
Consolidated net income
95.4
93.4
+2.0 M
Group share of net income
92.2
92.3
-0.1 M
Vilmorin & Cie's consolidated financial information has been established, at the close of fiscal year 2021-2022, in compliance with the IFRS reference (International Financial Reporting Standards) as applied by the European Union on June 30,2022. Consolidated sales, corresponding to revenue from ordinary activities for fiscal year 2021-2022 came to 1,587.2 million euros, an increase of 7.5% with current data, and 6.2% on a like-for-like basis compared with 2020-2021. In spite of a general context that was destabilized by the Russian-Ukrainian conflict, Vilmorin & Cie managed to exceed its objective for growth in consolidated sales as revised at the end of the third quarter of the fiscal year (i.e. growth of around 5% on a comparable basis)1.
After taking into account the cost of destruction and depreciation of inventory, the margin on the cost of goods stood at 48.6%, a decrease of 0.7 percentage points compared with 2020-2021.
Net operating charges came to 635.2 million euros, as opposed to 600.6million euros on June30, 2021.
In compliance with its strategic orientations, Vilmorin & Cie pursued its research programs, both in terms of conventional plant breeding and biotechnologies. Total research investment came to 275.1 million euros, as opposed to 257.0 million euros in 2020-2021, and represents 16.2% of seed activity sales2, which is in line with the average of the previous three fiscal years.
The consolidated operating income stood at 136.3 million euros, an increase compared to the previous fiscal year (127.4 million euros) for all the seeds activities, including Garden Products, resulting in a current operating margin rate of 8.6%, slightly lower by 0.3 percentage points compared with fiscal year 2020-2021.
The share of income from associated companies came to 17.9 million euros, a marked decrease of 8.4 million euros compared with the previous fiscal year, due in particular to a deterioration in the operating performance of AgReliant (North America. Field Seeds) and the impact of hyperinflation, which severely limited the performance of Seed Co in Zimbabwe (Africa. Field Seeds).
The financial result showed a net charge of 33.4 million euros as opposed to 46.9 million euros in 2020-2021, an improvement of 13.5 million euros, mainly due to lower currency exchange losses.
The net charge of income taxes deteriorated by 12.0 million euros, and stood at 25.4 million euros as opposed to 13.4 million euros in 2020-2021, mainly the result of a deterioration in the deferred tax position of 10.6 million euros, partly attributable to hyperinflation in Argentina (under local standards) and in Turkey.
Vilmorin & Cie's total net income came to 95.4 million euros, an increase of 2.0 million euros compared to the previous fiscal year. This is the highest net income since fiscal year 2012-2013. The group share ("attributable to the controlling Company") stood at92.2 million euros.
Net of cash and cash equivalents (321.3 million euros), total financial indebtedness came to 901.1 million euros on June 30, 2022 compared with 867.4 million euros on June 30, 2021. The share of non-current financial indebtedness stood at 1,088.3 million euros, compared with 994.8 million euros the previous year. The group's share of equity stood at1,434.6million euros and minority interests at 48.8 million euros, with a significant increase over the fiscal year, due to the high level of net income and an increase in translation reserves linked to the appreciation of the US dollar.
Thus, compared with the previous fiscal year, the balance sheet structure on June 30, 2022 was marked by a decrease in the ratio of net indebtedness to equity (a gearing of 61%, compared to 65% on June 30, 2021). The leverage ratio as of June 30, 2022 was 2.3x compared with 2.4x as of June 30, 2021, reflecting an improvement in the group's debt reduction capacity.
2022 dividend:Proposal of a dividend of 1.60 euros per share at the upcoming Annual General Meeting of Shareholders, in Auvergne
A dividend of 1.60 euros per share, stable compared to the dividend of the previous fiscal year, will be proposed this year. This corresponds to a distribution rate of 39.8%.
This dividend will be submitted to the vote of the Shareholders by the Board of Directors of Vilmorin & Cie, on the occasion of the Annual General Meeting of Shareholders of December 9, 2022, which will be held in the Auvergne-Rhne-Alpes region, where Limagrain, the parent company and reference shareholder of the Company, is located.
Dividends will be detached on December 13, 2021, with payment on December 15, 2021.
News:A new research partnership concerning pulses in Canada
As explained when sales for the fiscal year 2021-2022 were disclosed, Vilmorin & Cie, through its Field Seeds division, announced the signing of a new partnership with Saskatchewan Pulse Growers3, in July 2022, to set up a joint research and innovation program for pulses, more particularly dry peas and lentils.
This new program, co-financed equally by the two parties, will be based in Saskatoon (Province of Saskatchewan, Canada), where the Limagrain Cereals Research Canada4 joint venture is already established, and will respond directly to the needs of farmers and to major production challenges. Among the targeted goals are resistance to root diseases, increased protein content and, above all, improved yields under variable growing conditions. With the help of a dedicated team, the objective is to bring new expertise to the region in terms of breeding, molecular genetics, treatment of pathologies and field trials.
Canada is the world's largest producer of pulse crops, with more than 2.3 million hectares planted each year5.
Objectives for 2022-2023:
Business growth of between 6% and 8%6and a current operating margin rate of at least 8%
Market conditions for fiscal year 2022-2023 are likely to remain uncertain and fluctuating, due to inflationary pressures resulting, in particular, from the geopolitical context. In this environment, Vilmorin & Cie will continue to play its role as a leading seed company by continuing to strengthen its competitive positions; the Company will pursue its measured investment in research & development, in particular in upstream technologies, while remaining attentive to any opportunity for external growth, in line with its strategic challenges and foundations.
For fiscal year 2022-2023, Vilmorin & Cie has set itself the objective of achieving an increase in consolidated sales of between 6% and 8%6, excluding the positive impact of the EGalim law on sales (which will however be neutral concerning the operating income) 7.
The Company is aiming for a current operating margin rate of at least 8%, impacted by the evolution of its business mix in favor of Field Seeds. This rate will take into account investment into research at a similar level, as a percentage of sales, to that of the two previous fiscal years, and spread evenly between Vegetable Seeds and Field Seeds.
Finally, Vilmorin & Cie is aiming for a contribution from associated companies - mainly AgReliant (North America. Field Seeds), Seed Co (Africa. Field Seeds) and AGT (Australia. Field Seeds) - at least equal to that of fiscal year 2021-2022.
Vilmorin & Cie's commercial prospects in Ukraine-RussiaIn Ukraine, the outlook for the coming fiscal year remains moderate, due to the difficulty of local farmers and distributors to obtain funding and, more generally, the lack of visibility in the region due to the continuing conflict with Russia. Accordingly, the Company expects a level of activity similar to that of fiscal year 2021-2022.
In Russia, thanks to the performance of its sunflower and corn seed varieties in particular, Vilmorin & Cie intends to confirm the momentum observed during the previous fiscal year. Prospects to date are favorable, but their realization remains subject to growing logistical and geopolitical problems, to which the Company is striving to find solutions.
Anthony CARVALHO, Vilmorin & Cie's new Chief Financial Officer
As announced in the press release of its sales for fiscal year 2021-2022, Vilmorin & Cie appointed Anthony CARVALHO to its Executive Committee, on September 14, 2022, as Chief Financial Officer.
Anthony CARVALHO, 33, holds a Master's degree in Information Systems from the Institut Mines-Tlcom SudParis, and also a Master's degree in Audit & Financial Advisory from the University of Paris Dauphine and a Master's degree in Finance from ESSEC. He has significant experience in financial functions, acquired in investment funds and then as Head of the integrated Family Office of the Roullier Group. He also has experience in Audit and Advisory, acquired within Deloitte. Previously, Anthony CARVALHO was, as of September 2021, Chief Financial Officer of the Roullier Group.
Coming disclosures and events
For any further information
Tuesday November 8, 2022*Disclosure of salesfor the first quarter of 2022-2023
Friday December 9, 2022Annual General Meeting of Shareholders
Tuesday December 13, 2022Detachment of the dividends
Thursday December 15, 2022Payment of the dividends
* Disclosure after trading on the Paris stock market.Dates provided as an indication only, and liable to be changed.
Anthony CARVALHOChief Financial Officer
douard ROCHEHead of Financial Communication and Investor Relations
See more here:
Results for the fiscal year on June 30, 2022 - Yahoo Finance
- Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit [Last Updated On: April 26th, 2012] [Originally Added On: April 26th, 2012]
- Protein could be key for drugs that promote bone growth [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- Study sheds light on genetic 'clock' in embryonic cells [Last Updated On: November 14th, 2012] [Originally Added On: November 14th, 2012]
- Study involving twin sisters provides clues for battling aggressive cancers [Last Updated On: February 9th, 2014] [Originally Added On: February 9th, 2014]
- Clues for battling aggressive cancers from twin sisters study [Last Updated On: February 11th, 2014] [Originally Added On: February 11th, 2014]
- Genetic cause found for premature ovarian failure [Last Updated On: March 6th, 2014] [Originally Added On: March 6th, 2014]
- Rutgers' Human Genetics Institute Wins $19 Million Federal Contract [Last Updated On: May 15th, 2014] [Originally Added On: May 15th, 2014]
- Elsevier Publishes Four New Books in Microbiology Portfolio [Last Updated On: November 13th, 2014] [Originally Added On: November 13th, 2014]
- Disease, Evolution, Neurology, and Drugs: Fruit Fly Research Continues to Teach Us About Human Biology [Last Updated On: February 28th, 2015] [Originally Added On: February 28th, 2015]
- "Big Brain" Gene Allowed for Evolutionary Expansion of Human Neocortex [Last Updated On: March 8th, 2015] [Originally Added On: March 8th, 2015]
- Director Molecular Genetics jobs in Rtp at LabCorp [Last Updated On: June 1st, 2015] [Originally Added On: June 1st, 2015]
- Molecular Genetics definition of Molecular Genetics in the ... [Last Updated On: June 4th, 2015] [Originally Added On: June 4th, 2015]
- molecular and human genetics | Momentum - The Baylor ... [Last Updated On: June 19th, 2015] [Originally Added On: June 19th, 2015]
- Molecular evolution - Wikipedia, the free encyclopedia [Last Updated On: July 16th, 2015] [Originally Added On: July 16th, 2015]
- The Rockefeller University Laboratory of Molecular Genetics [Last Updated On: July 21st, 2015] [Originally Added On: July 21st, 2015]
- Microbiology & Molecular Genetics - Rutgers New Jersey ... [Last Updated On: September 5th, 2015] [Originally Added On: September 5th, 2015]
- Clinical Genetics Congress | Clinical Genetics 2016 ... [Last Updated On: September 28th, 2016] [Originally Added On: September 28th, 2016]
- Molecular genetics - Wikipedia, the free encyclopedia [Last Updated On: September 28th, 2016] [Originally Added On: September 28th, 2016]
- Molecular Genetics - DNA, RNA, & Protein [Last Updated On: October 20th, 2016] [Originally Added On: October 20th, 2016]
- MCW: Microbiology and Molecular Genetics Department [Last Updated On: October 21st, 2016] [Originally Added On: October 21st, 2016]
- Newcastle Hospitals - Molecular Genetics [Last Updated On: October 21st, 2016] [Originally Added On: October 21st, 2016]
- Molecular evolution - Wikipedia [Last Updated On: October 23rd, 2016] [Originally Added On: October 23rd, 2016]
- Molecular Genetics (Stanford Encyclopedia of Philosophy) [Last Updated On: October 30th, 2016] [Originally Added On: October 30th, 2016]
- Molecular Genetics - mmrl.edu [Last Updated On: November 12th, 2016] [Originally Added On: November 12th, 2016]
- Molecular biology - Wikipedia [Last Updated On: November 12th, 2016] [Originally Added On: November 12th, 2016]
- Human Molecular Genetics - amazon.com [Last Updated On: November 12th, 2016] [Originally Added On: November 12th, 2016]
- Molecular Genetics Service - Great Ormond Street Hospital ... [Last Updated On: November 16th, 2016] [Originally Added On: November 16th, 2016]
- The Passions of Nazneen Rahman - San Francisco Classical Voice [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Genetic Testing for the Healthy - Harvard Medical School (registration) [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Fundraising page set up in memory of Nottingham's Maid Marian - Nottingham Post [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Dogs have their day at conference - Otago Daily Times [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- GGC Graduates Two from Medical Genetics Training Program - Index-Journal [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Irvine-based CombiMatrix in $33 million merger deal with Bay Area genetics firm - OCRegister [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- First of 10 expected BJC Investigators named - Washington University School of Medicine in St. Louis [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- Madhuri Hegde, PhD is Elected to the Board of the ACMG Foundation for Genetic and Genomic Medicine - Markets Insider [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- Getting the word out: Seminar, walk put spotlight on Sickle Cell disease - Dothan Eagle [Last Updated On: August 31st, 2017] [Originally Added On: August 31st, 2017]
- Out of a fish gut study, researchers open new doors in intestinal health - Durham Herald Sun [Last Updated On: August 31st, 2017] [Originally Added On: August 31st, 2017]
- Gene-Silencing Finding May Lead to Better Understanding of Some ... - Genetic Engineering & Biotechnology News [Last Updated On: August 31st, 2017] [Originally Added On: August 31st, 2017]
- Molecular Genetics and Genomics Program - Wake Forest ... [Last Updated On: October 1st, 2017] [Originally Added On: October 1st, 2017]
- Genetics and Molecular Biology | Peer Reviewed Journal [Last Updated On: June 30th, 2018] [Originally Added On: June 30th, 2018]
- Leeds Genetics Laboratory - Leeds Teaching Hospitals NHS Trust [Last Updated On: July 17th, 2018] [Originally Added On: July 17th, 2018]
- Genetics and Molecular Biology Research - iMedPub [Last Updated On: August 2nd, 2018] [Originally Added On: August 2nd, 2018]
- Molecular Genetics | ARUP Laboratories [Last Updated On: August 7th, 2018] [Originally Added On: August 7th, 2018]
- Molecular Genetics - The Ohio State University [Last Updated On: August 21st, 2018] [Originally Added On: August 21st, 2018]
- Peer Reviewed Genetics and Molecular Biology Journals ... [Last Updated On: September 5th, 2018] [Originally Added On: September 5th, 2018]
- Department of Microbiology and Molecular Genetics [Last Updated On: October 7th, 2018] [Originally Added On: October 7th, 2018]
- Molecular Genetics Jobs, Employment | Indeed.com [Last Updated On: October 10th, 2018] [Originally Added On: October 10th, 2018]
- Genomic Career: Molecular Geneticist ($35,620-$101,030) [Last Updated On: October 10th, 2018] [Originally Added On: October 10th, 2018]
- Molecular Genetics, Biochemistry & Microbiology [Last Updated On: October 10th, 2018] [Originally Added On: October 10th, 2018]
- Molecular Genetics | Department of Pediatrics [Last Updated On: December 1st, 2018] [Originally Added On: December 1st, 2018]
- Graduate Molecular Genetics - University of Toronto [Last Updated On: January 25th, 2019] [Originally Added On: January 25th, 2019]
- Molecular Genetics - OCME - nyc.gov [Last Updated On: February 19th, 2019] [Originally Added On: February 19th, 2019]
- Molecular Genetics - University of Toronto [Last Updated On: March 6th, 2019] [Originally Added On: March 6th, 2019]
- Department of Microbiology, Immunology and Molecular Genetics [Last Updated On: March 13th, 2019] [Originally Added On: March 13th, 2019]
- Molecular Genetics and Cell Biology [Last Updated On: May 4th, 2019] [Originally Added On: May 4th, 2019]
- Molecular Reproduction, Development and Genetics at IISc [Last Updated On: May 18th, 2019] [Originally Added On: May 18th, 2019]
- Molecular genetics | biology | Britannica.com [Last Updated On: September 7th, 2019] [Originally Added On: September 7th, 2019]
- BCH N of 1 Trial Yields Approved Therapy for Single Rare Disease Patient - Clinical OMICs News [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- 5 habits of highly successful entrepreneurs revealed - GrowthBusiness.co.uk [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- Leading by example: how AquaBounty, Oxford Biomedica, and Berkeley Lights have successfully brought products to market - SynBioBeta [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- Blue Devil of the Week: Searching for Answers in the Genetic Code - Duke Today [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- New Viruses Found in Farmed and Wild Salmon - Hakai Magazine [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- Veterinary Molecular Diagnostics Market to Reach at a CAGR of 8.48% by 2026 With NEOGEN CORPORATION , Thermo Fisher Scientific, Inc., Virbac, General... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Quantabio to Showcase Industry's Fastest qPCR-based NGS Library Quantification Kit and HiFi PCR Mix at American Society of Human Genetics Annual... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Top Researchers to Present Discoveries Made Possible by Bionanos Saphyr System for Genome Imaging Technology at the ASHG 2019 Annual Meeting - Yahoo... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Bionano Genomics Announces Adoption of Its Saphyr System by Clinical Cytogenetics Groups in Academia and Industry to Replace Traditional Methods for... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Racial Disparities In NIH R01 Funding May Be Partly Caused By Topic Choice : Shots - Health News - NPR [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Denison presents: 'Christianity, Race, and the Haunting of the Biomedical Sciences' - The Newark Advocate [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- This image shows the aftermath of two galaxies colliding - CTV News [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Meet The Cast of Charmed Season 2 - TVOvermind [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Inherited Learning? It Happens, but How Is Uncertain - Quanta Magazine [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Where do Canada's federal parties stand on research funding? - Varsity [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- The double bind faced by black research applicants - University World News [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Excessive Brain Activity Linked to Shorter Life Span - PsychCentral.com [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board - PRNewswire [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Lupus Study Illustrates the Importance of Diversity in Genetic Research - Nature World News [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- Interpace to Present Data at the ATA Annual Meeting - GlobeNewswire [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- Pacific subspecies of fin whales has been revealed by new genetic study - Oceanographic - Oceanographic Magazine [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- Genetic Study: Shared Molecular Pathway Might Influence Susceptibility to Lack of Oxygen Caused by Sleep-disordered Breathing and Other Lung Illnesses... [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- ERT to Treat Pompe May Work Better in Combo with Blood Pressure Medication, Study Says - Pompe Disease News [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]